- Home
- FSBC vs SEPN Comparison
FSBC vs SEPN Comparison
Compare FSBC & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- SEPN
- Stock Information
- Founded
- FSBC 2002
- SEPN 2022
- Country
- FSBC United States
- SEPN United States
- Employees
- FSBC N/A
- SEPN N/A
- Industry
- FSBC Banks
- SEPN
- Sector
- FSBC Finance
- SEPN
- Exchange
- FSBC Nasdaq
- SEPN NYSE
- Market Cap
- FSBC 565.6M
- SEPN 522.7M
- IPO Year
- FSBC 2021
- SEPN 2024
- Fundamental
- Price
- FSBC $30.59
- SEPN $12.64
- Analyst Decision
- FSBC Buy
- SEPN Strong Buy
- Analyst Count
- FSBC 5
- SEPN 5
- Target Price
- FSBC $34.80
- SEPN $26.75
- AVG Volume (30 Days)
- FSBC 38.9K
- SEPN 246.0K
- Earning Date
- FSBC 07-23-2025
- SEPN 08-15-2025
- Dividend Yield
- FSBC 2.62%
- SEPN N/A
- EPS Growth
- FSBC 2.43
- SEPN N/A
- EPS
- FSBC 2.44
- SEPN N/A
- Revenue
- FSBC $132,133,000.00
- SEPN $977,000.00
- Revenue This Year
- FSBC $26.05
- SEPN $3,429.67
- Revenue Next Year
- FSBC $15.06
- SEPN N/A
- P/E Ratio
- FSBC $12.53
- SEPN N/A
- Revenue Growth
- FSBC 18.01
- SEPN 108.76
- 52 Week Low
- FSBC $22.22
- SEPN $4.17
- 52 Week High
- FSBC $35.13
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- FSBC 56.91
- SEPN N/A
- Support Level
- FSBC $29.56
- SEPN N/A
- Resistance Level
- FSBC $31.40
- SEPN N/A
- Average True Range (ATR)
- FSBC 0.87
- SEPN 0.00
- MACD
- FSBC -0.03
- SEPN 0.00
- Stochastic Oscillator
- FSBC 56.10
- SEPN 0.00
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.